STAT

Genome ‘writers’ set their first goal: recoding human cells to resist viruses

Scientists participating in Genome Project-write announced their first target: creating human cells that could never be infected by viruses and might also be resistant to other killers.

Its birth in 2016 was greeted with near hysteria over “secret meetings” and dire warnings about hubristic scientists creating made-from-scratch human genomes and designer babies. Its first birthday was overshadowed by the little matter of falling $99.75 million short of the $100 million fundraising goal it had very publicly set.

But two years in, an ambitious project to synthesize genomes — including human ones — is moving on from its shaky start and plunging in to the practical work of creating better genomes than nature did. As some 200 scientists participating in “Genome Project-write” met in Boston on Tuesday, the group announced its first target: creating cells that could

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks